Johnson & Johnson (ETR:JNJ)

Market Cap	460.84B +35.9%
Revenue (ttm)	80.06B +6.0%
Net Income	22.78B +90.6%
EPS	9.38 +90.5%
Shares Out	n/a
PE Ratio	20.23
Forward PE	19.50
Dividend	4.57 (2.40%)
Ex-Dividend Date	Nov 25, 2025

Volume	2,287
Average Volume	3,826
Open	192.98
Previous Close	190.54
Day's Range	191.80 - 192.98
52-Week Range	128.16 - 192.98
Beta	0.33
RSI	65.70
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: JNJ

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD